anthralin has been researched along with cyclosporine in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (34.62) | 18.2507 |
| 2000's | 11 (42.31) | 29.6817 |
| 2010's | 5 (19.23) | 24.3611 |
| 2020's | 1 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Lewis, HM | 1 |
| Burger, PM; Goos, M; Nussbaum, G; Ockenfels, HM; Schultewolter, T | 1 |
| Gilleaudeau, P; Gottlieb, AB; Gottlieb, SL; Heftler, NS; Johnson, R; Krueger, JG; Vallat, VP; Wolfe, J | 1 |
| Friedmann, PS; Levell, NJ; Munro, CS; Shuster, S | 1 |
| Färber, L; Mahrle, G; Schulze, HJ; Steigleder, GK; Weidinger, G | 1 |
| Dobozy, A; Kemény, L; Michel, G; Ruzicka, T | 1 |
| Dobozy, A; Farkas, B; Kemény, L; Kenderessy, AS; Michel, G; Olasz, E; Ruzicka, T | 1 |
| Kragballe, K | 1 |
| Burgers, SA; van Vloten, WA | 1 |
| Feldman, S | 1 |
| Blomqvist, K; Davidsson, S; Molin, L; Mørk, C; Sigurgeirsson, B; Zachariae, H; Zachariae, R | 1 |
| Benes, P; Benz, RE; Färber, L; Langendorf, Y; Schopf, RE | 1 |
| Naldi, L; Rzany, B | 3 |
| Ceović, R; Husar, K; Kostović, K; Lipozencić, J; Murat-Susić, S; Pasić, A; Skerlev, M | 1 |
| Gyulai, R; Kemény, L | 1 |
| Jiaravuthisan, MM; Muhn, CY; Murphy, F; Sasseville, D; Vender, RB | 1 |
| Stiefelhagen, P | 1 |
| Shapiro, J | 1 |
| Perera, E; Sinclair, R; Yip, L | 1 |
| Arnone, M; Azulay-Abulafia, L; Bernardo, WM; Bortoletto, MCC; Bressan, AL; Carvalho, AVE; Felix, PAO; Fieri, LC; Jaime, TJ; Magalhaes, RF; Neffá, JM; Nunes, DH; Oliveira, MFSP; Ramos, AMC; Romiti, R; Souza, CDS; Takahashi, MDF; Terena, AC | 1 |
| Armstrong, AW; Connor, C; Cordoro, KM; Davis, DMR; Elewski, BE; Elmets, CA; Farley Prater, EA; Gelfand, JM; Gordon, KB; Gottlieb, AB; Hariharan, V; Kaplan, DH; Kavanaugh, A; Kiselica, M; Kivelevitch, D; Korman, NJ; Kroshinsky, D; Lebwohl, M; Leonardi, CL; Lichten, J; Lim, HW; Mehta, NN; Menter, A; Paller, AS; Parra, SL; Pathy, AL; Rupani, RN; Siegel, M; Stoff, B; Strober, BE; Wong, EB; Wu, JJ | 1 |
12 review(s) available for anthralin and cyclosporine
| Article | Year |
|---|---|
Therapeutic progress. II: Treatment of psoriasis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Calcitriol; Coal Tar; Combined Modality Therapy; Cyclosporine; Dermatologic Agents; Emollients; Humans; Immunosuppressive Agents; Methotrexate; Phototherapy; Psoriasis; Retinoids; Tacrolimus; United Kingdom | 1994 |
Cytokine system as potential target for antipsoriatic therapy.
Topics: Anthralin; Cholecalciferol; Cyclosporine; Cytokines; Glucocorticoids; Humans; Keratinocytes; Psoriasis; Receptors, Cytokine; Retinoids; Ultraviolet Therapy | 1994 |
[Treatment of psoriasis].
Topics: Adrenal Cortex Hormones; Anthralin; Combined Modality Therapy; Cyclosporine; Humans; Methotrexate; Psoriasis; PUVA Therapy; Retinoids; Tars; Ultraviolet Therapy; Vitamin D | 1993 |
Advances in psoriasis treatment.
Topics: Acitretin; Administration, Topical; Anthralin; Anti-Inflammatory Agents; Coal Tar; Cyclosporine; Dermatologic Agents; Glucocorticoids; Humans; Methotrexate; Nicotinic Acids; Patient Education as Topic; Phototherapy; Psoriasis; PUVA Therapy; Quality of Life; Social Support; Triamcinolone | 2000 |
Chronic plaque psoriasis.
Topics: Anthralin; Combined Modality Therapy; Cyclosporine; Dermatologic Agents; Ficusin; Humans; Nicotinic Acids; Psoriasis; Retinoids; Ultraviolet Therapy; Vitamin D | 2004 |
Chronic plaque psoriasis.
Topics: Anthralin; Anti-Inflammatory Agents; Combined Modality Therapy; Cyclosporine; Humans; Immunosuppressive Agents; Methotrexate; Psoriasis; PUVA Therapy; Retinoids; Ultraviolet Therapy; Vitamin D | 2005 |
Chronic plaque psoriasis.
Topics: Adrenal Cortex Hormones; Alefacept; Anthralin; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Combined Modality Therapy; Cyclosporine; Cytokines; Dermatologic Agents; Humans; Methotrexate; Nicotinic Acids; Psoriasis; PUVA Therapy; Recombinant Fusion Proteins; Retinoids; Ultraviolet Therapy; Vitamin D | 2006 |
Treatment of childhood psoriasis.
Topics: Adrenal Cortex Hormones; Anthralin; Calcitriol; Child; Cyclosporine; Humans; Methotrexate; Nicotinic Acids; Phototherapy; Psoriasis; Retinoids | 2006 |
[The immunology of psoriasis: from basic research to the bedside].
Topics: Acitretin; Adrenal Cortex Hormones; Alefacept; Anthralin; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Autoimmunity; Biomedical Research; Cell Differentiation; Cell Proliferation; Cyclosporine; Dermatologic Agents; Humans; Immunity, Cellular; Immunosuppressive Agents; Infliximab; Keratinocytes; Keratolytic Agents; Methotrexate; Psoriasis; Recombinant Fusion Proteins; T-Lymphocytes, Regulatory; Ultraviolet Therapy | 2006 |
Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Clinical Trials as Topic; Cyclosporine; Fluorouracil; Humans; Injections, Intralesional; Nail Diseases; Nails; Nicotinic Acids; Photochemotherapy; Phototherapy; Psoriasis | 2007 |
Current treatment of alopecia areata.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Alopecia Areata; Anthralin; Cyclobutanes; Cyclopropanes; Cyclosporine; Dermatologic Agents; Humans; Immunosuppressive Agents; Injections, Intralesional; Methotrexate; Minoxidil; PUVA Therapy; Self-Help Groups | 2013 |
Alopecia areata.
Topics: Administration, Topical; Adrenal Cortex Hormones; Alopecia Areata; Anthralin; Autoimmunity; Cyclopropanes; Cyclosporine; Dermatitis, Allergic Contact; Dermatologic Agents; Humans; Immunosuppressive Agents; Immunotherapy; Injections, Intralesional; Minoxidil; Vasodilator Agents | 2015 |
3 trial(s) available for anthralin and cyclosporine
| Article | Year |
|---|---|
Remission of ordinary psoriasis following a short clearance course of cyclosporin.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Aged; Anthralin; Arthritis; Blood Pressure; Creatinine; Cyclosporine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nail Diseases; Photochemotherapy; Psoriasis; Recurrence; Remission Induction; Ultraviolet Therapy | 1995 |
Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
Topics: Administration, Cutaneous; Adult; Anthralin; Arthritis, Psoriatic; Blood Pressure; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Etretinate; Female; Follow-Up Studies; Germany; Humans; Male; Middle Aged; Nail Diseases; Psoriasis; Recurrence; Severity of Illness Index; Skin; Time Factors; Treatment Outcome | 1995 |
A highly decreased binding of cyclic adenosine monophosphate to protein kinase A in erythrocyte membranes is specific for active psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Affinity Labels; Aged; Anthralin; Anti-Inflammatory Agents; Azides; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclosporine; Dermatologic Agents; Erythrocyte Membrane; Etretinate; Female; Humans; Keratolytic Agents; Male; Middle Aged; Protein Binding; Psoriasis; Retinoids; Severity of Illness Index | 2002 |
11 other study(ies) available for anthralin and cyclosporine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Cyclosporin A, FK506 and dithranol after tyrosine-specific protein phosphorylation in HaCaT keratinocytes.
Topics: Anthralin; Cell Line; Cyclosporine; Humans; Immunohistochemistry; Indoles; Intracellular Fluid; Keratinocytes; Organ Culture Techniques; Phosphorylation; Phosphotyrosine; Protein Kinase C; Protein-Tyrosine Kinases; Proteins; Psoriasis; Signal Transduction; Skin; Tacrolimus; Tyrosine | 1995 |
Short-contact anthralin treatment augments therapeutic efficacy of cyclosporine in psoriasis: a clinical and pathologic study.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Anthralin; CD8-Positive T-Lymphocytes; Cell Division; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Epidermis; Female; Humans; Keratinocytes; Keratins; Lymphocyte Count; Lymphokines; Male; Middle Aged; Psoriasis; Remission Induction; Skin; T-Lymphocytes | 1995 |
The interleukin-8 receptor: a potential target for antipsoriatic therapy?
Topics: Anthralin; Calcitriol; Cells, Cultured; Cyclosporine; Flow Cytometry; HLA-DR Antigens; Humans; Interleukin-8; Keratinocytes; Neutrophils; Psoriasis; Receptors, Interleukin; Receptors, Interleukin-8A; Recombinant Proteins | 1994 |
[Findings in children with psoriasis].
Topics: Adolescent; Adrenal Cortex Hormones; Anthralin; Anti-Inflammatory Agents; Aspirin; Calcitriol; Child; Cyclosporine; Dermatologic Agents; Female; Genetic Predisposition to Disease; Humans; Male; Phototherapy; Psoriasis; Retrospective Studies; Tars; Treatment Outcome; Tretinoin | 1999 |
Treatment of psoriasis in the Nordic countries: a questionnaire survey from 5739 members of the psoriasis associations data from the Nordic Quality of Life Study.
Topics: Administration, Topical; Analysis of Variance; Anthralin; Anti-Inflammatory Agents; Calcitriol; Complementary Therapies; Cyclosporine; Dermatologic Agents; Europe; Female; Health Care Surveys; Humans; Male; Methotrexate; Middle Aged; Psoriasis; PUVA Therapy; Steroids; Surveys and Questionnaires | 2001 |
[Therapeutic strategies against psoriasis. Skin to hide -- and how do you free your patients from it].
Topics: Adrenal Cortex Hormones; Anthralin; Arthritis, Psoriatic; Biological Products; Cyclosporine; Dermatologic Agents; Female; Fumarates; Humans; Male; Methotrexate; Phototherapy; Psoriasis; PUVA Therapy; Retinoids; Sex Factors | 2007 |
Childhood psoriasis: often favorable outcome.
Topics: Acitretin; Administration, Topical; Anthralin; Calcitriol; Child; Cyclosporine; Dermatologic Agents; Emollients; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agents; Methotrexate; Nicotinic Acids; Plant Extracts; Psoriasis; Receptors, Tumor Necrosis Factor; Salicylates; Steroids; Tars; Treatment Outcome; Ultraviolet Therapy | 2009 |
Diagnostic and therapeutic guidelines for plaque psoriasis - Brazilian Society of Dermatology.
Topics: Adrenal Cortex Hormones; Anthralin; Antibodies, Monoclonal; Brazil; Calcineurin Inhibitors; Comorbidity; Cyclosporine; Dermatologic Agents; Dermatology; Drug Combinations; Female; Humans; Male; Methotrexate; Phototherapy; Psoriasis; Severity of Illness Index; Societies, Medical; Time Factors; Vitamin D | 2019 |
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients.
Topics: Adolescent; Adrenal Cortex Hormones; Anthralin; Biological Products; Calcineurin Inhibitors; Cardiovascular Diseases; Child; Child, Preschool; Coal Tar; Comorbidity; Cyclosporine; Dermatologic Agents; Dyslipidemias; Evidence-Based Medicine; Humans; Infant; Infant, Newborn; Inflammatory Bowel Diseases; Insulin Resistance; Mental Health; Metabolic Syndrome; Methotrexate; Nicotinic Acids; Obesity; Photochemotherapy; Psoriasis; Retinoids | 2020 |